To investigate if progression from prodromal into symptomatic NPH can be predicted from advanced neuroimaging, biomarkers in cerebrospinal fluid (CSF) and plasma and investigate the unknown mechanisms causing deterioration by investigating longitudinal changes in the above-mentioned variables. Three different cohorts with both asymptomatic and symptomatic patients as well as healthy controls will be investigated over time, both without intervention and before and after shunt surgery.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Frequency of patients with prodromal iNPH that requires shunt surgery within 6 years from inclusion.
Timeframe: From date of inclusion until decision of shunt surgery, assessed up to 72 months
Frequency of patients with prodromal iNPH that progress to symptomatic iNPH
Timeframe: From date of inclusion until 20 points reduction in total iNPH-scale score or 20% reduction in gait speed, assessed up to 72 months
Post operative improvement in iNPH-scale score in patients with mild, moderate and severe preoperative symptoms
Timeframe: Change from preoperative (last visit before surgery) iNPH scale at 3 months, 12 months, 36 months and 60 months follow-up.